Treatment with the proteasome inhibitor MG132 showed negligible effects on Pin1 expression in GSCs but markedly restored Pin1 protein levels in the matched non-stem tumor cells (NSTCs) (Fig. 1a, Supplementary Fig. 1a). This evidence concerns the gene PIN1 and neoplasm.